1031703-38-4

Basic information

• Product Name: 2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethanol-1,1,2,2-D₄
• Synonyms: 2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethanol-1,1,2,2-D₄
• CAS NO: 1031703-38-4
• Molecular Weight: 343.429
• Mol File: 1031703-38-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethanol-1,1,2,2-D₄(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethanol-1,1,2,2-D₄(1031703-38-4)
• EPA Substance Registry System: 2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethanol-1,1,2,2-D₄(1031703-38-4)

Safety Data

• Hazardous Substances Data: 1031703-38-4(Hazardous Substances Data)

Upstream product

• 5747-48-8 11-(1-piperazinyl)dibenzo[b,f][1,4]thiazepine 
• 117067-62-6 2-chloroethanol-d₄ 

Relevant articles and documents

DIBENZOTHIAZEPINE DERIVATIVES

This invention relates to novel 11-[4-[2-(2-Hydroxyethoxy)ethyl]piperazin-1- y1]dibenzo[b,f][1,4]thiazepine derivatives, their acceptable acid addition salts, solvates, hydrates and polymorphs thereof. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by antagonists of seratonergic 5HT1A and 5HT2 receptors, dopaminergic D1 and D2 receptor, histaminergic H1 receptors, and/or adrenergic αl and α2 receptors.